Business

Sun Pharma up against challenges as it builds speciality biz in US

Sun Pharma up against challenges as it builds speciality biz in US "We committed close to a $1 billion on specialty business, we have to justify that investment and produce returns," Dilip Shanghvi said in the company#39;s earnings call on February 12.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts